BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35304331)

  • 1. A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.
    Verzijl CRC; Oldoni F; Loaiza N; Wolters JC; Rimbert A; Tian E; Yang W; Struik D; Smit M; Kloosterhuis NJ; Fernandez AJ; Samara NL; Ten Hagen KG; Dalal K; Chernish A; McCluggage P; Tabak LA; Jonker JW; Kuivenhoven JA
    Mol Metab; 2022 Jun; 60():101472. PubMed ID: 35304331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents.
    Khetarpal SA; Schjoldager KT; Christoffersen C; Raghavan A; Edmondson AC; Reutter HM; Ahmed B; Ouazzani R; Peloso GM; Vitali C; Zhao W; Somasundara AV; Millar JS; Park Y; Fernando G; Livanov V; Choi S; Noé E; Patel P; Ho SP; ; Kirchgessner TG; Wandall HH; Hansen L; Bennett EP; Vakhrushev SY; Saleheen D; Kathiresan S; Brown CD; Abou Jamra R; LeGuern E; Clausen H; Rader DJ
    Cell Metab; 2016 Aug; 24(2):234-45. PubMed ID: 27508872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function.
    Zilmer M; Edmondson AC; Khetarpal SA; Alesi V; Zaki MS; Rostasy K; Madsen CG; Lepri FR; Sinibaldi L; Cusmai R; Novelli A; Issa MY; Fenger CD; Abou Jamra R; Reutter H; Briuglia S; Agolini E; Hansen L; Petäjä-Repo UE; Hintze J; Raymond KM; Liedtke K; Stanley V; Musaev D; Gleeson JG; Vitali C; O'Brien WT; Gardella E; Rubboli G; Rader DJ; Schjoldager KT; Møller RS
    Brain; 2020 Apr; 143(4):1114-1126. PubMed ID: 32293671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis.
    Antonucci A; Marucci A; Trischitta V; Di Paola R
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder.
    Yang W; Tian E; Chernish A; McCluggage P; Dalal K; Lara A; Ten Hagen KG; Tabak LA
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303703120. PubMed ID: 37862385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.
    Schjoldager KT; Vester-Christensen MB; Bennett EP; Levery SB; Schwientek T; Yin W; Blixt O; Clausen H
    J Biol Chem; 2010 Nov; 285(47):36293-303. PubMed ID: 20837471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.
    Holleboom AG; Karlsson H; Lin RS; Beres TM; Sierts JA; Herman DS; Stroes ES; Aerts JM; Kastelein JJ; Motazacker MM; Dallinga-Thie GM; Levels JH; Zwinderman AH; Seidman JG; Seidman CE; Ljunggren S; Lefeber DJ; Morava E; Wevers RA; Fritz TA; Tabak LA; Lindahl M; Hovingh GK; Kuivenhoven JA
    Cell Metab; 2011 Dec; 14(6):811-8. PubMed ID: 22152306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy.
    Serino G; Sallustio F; Curci C; Cox SN; Pesce F; De Palma G; Schena FP
    Nephrol Dial Transplant; 2015 Jul; 30(7):1132-9. PubMed ID: 25744272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypeptide
    Kato K; Hansen L; Clausen H
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice.
    Li X; Zhang Y; Zhang M; Wang Y
    Sci Rep; 2020 Sep; 10(1):16168. PubMed ID: 32999434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by
    King SL; Goth CK; Eckhard U; Joshi HJ; Haue AD; Vakhrushev SY; Schjoldager KT; Overall CM; Wandall HH
    J Biol Chem; 2018 May; 293(20):7629-7644. PubMed ID: 29593093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific
    Goth CK; Tuhkanen HE; Khan H; Lackman JJ; Wang S; Narimatsu Y; Hansen LH; Overall CM; Clausen H; Schjoldager KT; Petäjä-Repo UE
    J Biol Chem; 2017 Mar; 292(11):4714-4726. PubMed ID: 28167537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
    Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
    Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
    Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
    Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.
    Liao YY; Chuang YT; Lin HY; Lin NY; Hsu TW; Hsieh SC; Chen ST; Hung JS; Yang HJ; Liang JT; Huang MC; Huang J
    Mol Oncol; 2023 Jan; 17(1):119-133. PubMed ID: 36409270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia.
    Di Paola R; Marucci A; Mangiacotti D; Antonucci A; Fontana A; Wang X; Qi L; Menzaghi C; Trischitta V
    Adv Biol (Weinh); 2023 Sep; 7(9):e2200319. PubMed ID: 36861373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
    Liu SY; Shun CT; Hung KY; Juan HF; Hsu CL; Huang MC; Lai IR
    Oncotarget; 2016 Mar; 7(10):11251-62. PubMed ID: 26848976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.